Chromadex

DSM Venturing strategically invests in ChromaDex

DSM Venturing strategically invests in ChromaDex

By Stephen DANIELLS

Chromadex has received equity financing from DSM Venturing, the corporate venture arm of Royal DSM, a move that will allow the Californian company to explore new topics and to accelerate its existing pipeline.

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers